Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Consensus Recommendation of “Buy” by Brokerages
Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) have been assigned an average recommendation of “Buy” from the eight research firms that are presently covering the company, MarketBeat reports. Eight investment analysts have rated the stock with a buy rating. The average twelve-month price target among brokers that have issued a report […]
Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) have been assigned an average recommendation of “Buy” from the eight research firms that are presently covering the company, MarketBeat reports. Eight investment analysts have rated the stock with a buy rating. The average twelve-month price target among brokers that have issued a report […]
